This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the probability of onset of TB infection; the probability of onset of TB disease given TB infection if prophylaxis was not administered; the efficacy of prophylaxis in the DO strategy and the non-DO strategy; the probability of onset of TB disease given TB infection if prophylaxis was administered; the probability of surviving TB; the probability of onset of hepatotoxicity; and the probability of surviving hepatotoxicity.
Study designs and other criteria for inclusion in the review
Not reported.
Sources searched to identify primary studies
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Approximately 21 primary studies were included in the review.
Methods of combining primary studies
The authors did not report the method used to combine outcome values from the primary studies. The probability of TB disease when prophylaxis is administered was calculated by multiplying the probability of TB disease associated with the no-prophylaxis strategy for patients who have TB infection by (1 minus efficacy).
Investigation of differences between primary studies
Results of the review
The probability of onset of TB infection was 0.001. The probability of onset of TB disease given TB infection if prophylaxis was not administered was 0.5.
The efficacy of prophylaxis was 0.8 in the DO strategy and 0.6 in the non-DO strategy.
The probability of surviving TB was 0.90. The probability of onset of hepatotoxicity was 0.001.
The results of the one-way sensitivity analysis of the probability of survival showed that the DO prophylaxis strategy was dominant (i.e. both more effective and less costly than no prophylaxis) under the following scenarios:
when the probability of developing infection was greater than 0.0002; when the probability of developing disease in the absence of prophylaxis was greater than 0.12; when the probability of dying of TB was greater than 0.025; when the probability of hepatotoxicity was less than 0.04; and when the probability of dying from hepatotoxicity was less than 0.04.
Authors' conclusions
The administration of prophylaxis was preferable to no administration of prophylaxis, unless the probability of infection was extremely low.
CRD COMMENTARY -Selection of comparators
An explicit justification was given for using no prophylaxis as the comparator. It represented current practice in the authors' settings. You should decide if the comparator used represents current practice in your own setting.
Validity of estimate of measure of effectiveness
The authors did not report that a systematic review of the literature had been undertaken to identify relevant research and minimise biases. However, a thorough literature review appears to have been undertaken as numerous studies, spanning a considerable range of publication dates, were included in the review. A large proportion of studies were published during the 1970s, with some even dating from before the 1950s. Consequently, it is likely that these studies may no longer be generalisable to current medical practice and patient populations. The authors provided very brief details of their review of the literature and the methods and assumptions they used to derive measures of effectiveness. It was also unclear which estimates were derived from the authors' own assumptions.
Validity of estimate of measure of benefit
The estimate of measure of benefits (i.e. survival) was derived from a decision tree model, which was appropriate for the study question. However, it would have been more appropriate, as an outcome measure, if the authors had converted survival (or deaths avoided) into life-years gained. Life-years gained is a more widely used and generalisable measure of outcome, and would therefore have been more useful for decision-makers.
Validity of estimate of costs
All the categories relevant to the health care system perspective adopted were included in the analysis. No major relevant costs appear to have been omitted. The resource use quantities and the unit costs were not reported separately, which will limit the generalisability of the authors' results. The costs were derived from hospital wards and clinics and, if unavailable, from the authors' own assumptions. As with measures of effectiveness, the authors did not report the assumptions they used or which costs were derived from their own assumptions. The authors performed sensitivity analyses, but it would appear that these were only carried out on effectiveness estimates and not on cost parameters.
